LATEST ARTICLES WRITTEN BY Julien

Image by Julien

Julian

Editor-in-Chief specializing in CBD, Julien, born July 17, 1978, in the Paris region, is a leading writer and expert in the field of CBD products. Following his studies, Julien developed a passion for natural remedies, including CBD. In 2022, he joined the CBD.fr team as an expert and regular contributor. Thanks to his scientific expertise and clear writing style, Julien helps demystify the complexities of CBD, while highlighting its benefits and potential applications through his articles and conference presentations.
Effects of CBD on the liver
About CBD

Liver and CBD: what do clinical trials and pharmacovigilance really reveal?

Cannabidiol (CBD), a key component of medical cannabis, is generating increasing interest for its potential therapeutic effects. The growing number of clinical trials and the accumulation of pharmacovigilance data are prompting a better understanding of its safety profile, particularly its impact on the liver. What signals are emerging? How should drug interactions and other factors be interpreted?

Drug/CBD Interactions
About CBD

Drug/CBD interactions: how to read a Vidal monograph

Cannabidiol (CBD) is generating increasing interest for its therapeutic effects, but its combination with various medications raises legitimate questions about drug interactions. Consulting a Vidal monograph is therefore a key step to ensure the safe use of CBD in patients undergoing treatment. Understanding how to decode

CBD and sleep
About CBD

Sleep and CBD: a review of the evidence 2025

The link between CBD and sleep is as intriguing as it is fascinating. In recent years, numerous studies have examined whether cannabidiol can offer concrete support to people suffering from sleep disorders. As the popularity of medical cannabis and CBD explodes in France and elsewhere, it is important to..

Legal CBD Grey Market
About CBD

Grey market vs. legal market for CBD: European mapping 2025

The lines between the grey market and the legal CBD market are constantly shifting in Europe, as CBD regulations and national strategies become clearer. Even though the European Union advocates for a degree of harmonization, each country retains its specificities, which complicates the trade and use of cannabidiol in Europe

CBD and high-level sport
About CBD

CBD and elite sport: doping, thresholds and recent case law

Cannabidiol (CBD) is generating increasing interest among elite athletes. Its status regarding doping has been evolving rapidly in recent years. Between regulatory changes, stricter anti-doping controls, and recent legal precedents, it is becoming essential for athletes, coaches, and doctors to understand the..

Novel Foods EFSA
About CBD

'Novel foods': where does EFSA stand?

The term "novel foods" refers to new foods, meaning ingredients that had no significant human consumption in the European Union before 1997. Since EU Regulation 2015/2283, a specific framework governs their evaluation and marketing authorization. The EFSA (European Food Safety Authority) plays a key role

CBD Insurance
About CBD

Insurance and CBD: guarantees, exclusions, what to declare when subscribing?

The rise of CBD and its wellness uses raises unprecedented questions for both policyholders and insurance companies. Whether you consume cannabidiol legally or are considering selling it, certain points warrant particular attention. In insurance matters, transparency prevents unpleasant surprises during a claim